29fintechM

Assignment explained - 02 - how to avoid assignment in options trading: practical tips for investors and traders

Options 10 minutes to read
MicrosoftTeams-image (3)
Koen Hoorelbeke

Investment and Options Strategist

How to avoid assignment in options trading: practical tips for investors and traders

This article is part of a four-part mini-series on option assignment—created for investors and active traders alike. Whether you're just starting out or deep into advanced strategies, understanding assignment will help you manage risk and opportunity more confidently.

This is part 2: How to avoid assignment.


Assignment is part of the game when you sell options—but it doesn’t have to catch you off guard. Whether you're an investor writing the occasional covered call or a trader actively managing multi-leg spreads, the key to avoiding unwanted assignment lies in understanding when and why it typically occurs—and taking action before it does.

Let’s start with the core concept: assignment happens when the buyer of an option chooses to exercise it. If you’ve sold that option, you’re now on the hook: you may need to buy or deliver 100 shares per contract. But contrary to what many fear, assignment doesn’t come out of nowhere. In almost every case, the warning signs are right there—if you know what to look for.


Focus on extrinsic value

One of the most useful indicators for predicting assignment risk is extrinsic value, also known as time value. This is the part of the option's price that reflects time left until expiration and expectations for volatility. The rest of the price is intrinsic value, which is the amount the option is in the money.

As long as a short option still has a decent amount of extrinsic value—say €0.20 or more—it’s unlikely to be exercised early. Why? Because the option buyer would lose that time value by exercising.

But once extrinsic value drops below €0.10, particularly when an option is in the money, the odds of assignment go up dramatically. At that point, there’s little benefit to holding the option, and exercising it to capture intrinsic value becomes more attractive—especially for call buyers just ahead of a dividend.

You can estimate extrinsic value in your Saxo platform by looking at how much of the option’s price reflects its time value. Here’s how it works: for a put option, if the strike price is higher than the stock price, the option has intrinsic value. For example, if you’ve sold a put with a €22 strike and the stock is trading at €17.80, the option has €4.20 of intrinsic value—because €22 minus €17.80 equals €4.20. If the option’s current price is €6.30, then the remaining €2.10 (6.30 minus 4.20) represents extrinsic value.

That part reflects how much time is left until expiration and any volatility premium. If that extrinsic value drops below €0.10, assignment becomes more likely.

If the result of the subtraction is negative, that simply means there’s no intrinsic value at all—the option is out of the money and carries only time value. In that case, there is no assignment risk, since exercising an out-of-the-money option would make no economic sense.

Example of a position having sold put-leg in the money
Example position with 1 leg (puts) in the money


Don’t let in-the-money status scare you

It’s important to understand that an option being in the money doesn’t automatically mean assignment is imminent. Traders often sell puts or calls that drift in the money, especially in high-volatility names. What matters more is how much time value is left.

Take the case shown in the screenshot above: the put is deep in the money, but the trader also holds a long call at the same strike. This is a synthetic long stock position. In this case, even though the short put is deep in the money, there's no real reason to fear assignment. That’s because the trader holds a long call at the same strike price, forming a synthetic long stock position. Whether assignment happens or not, the risk and payoff are effectively the same as owning the stock. The trader is already exposed to the same directional movement. In fact, with both legs in place, the strategy is balanced and self-hedging.

There's no urgent risk, no sudden margin surprise—just a shift in how the position is held. So even if the short put looks scary on its own, the overall structure is stable and intentional.


Be alert near expiration and dividends

Most early assignments happen just before expiration—especially on Friday. The closer you get to expiry, the more likely it is that your short in-the-money options will lose all their extrinsic value. For short calls, assignment risk spikes even earlier if there’s an upcoming dividend. That’s because call holders may want to exercise just to claim the payout.

One important point to remember: assignment never happens during market hours. It’s a back-office process that takes place after the close, typically based on end-of-day decisions from option holders. So during the trading day, you won’t suddenly find yourself assigned—there’s time to act. (For more details on how assignment processing works and when it shows up in your account, see Part 1: Assignment explained.)

A simple habit is to check your short options one or two days before expiration. If they're in the money and trading at or near their intrinsic value, you may want to close or roll them. The same goes for any short call that’s in the money heading into an ex-dividend date.


A few key examples

  • Covered call on a dividend stock: You sold a call at €48, and the stock is at €49.20 the day before ex-div. The call trades at €1.05. The dividend is €1.20. Since the option’s time value is less than the dividend, you’re at risk of being assigned. Roll the call or close it.
  • Cash-secured put nearing expiry: You sold a €22 put on a stock now trading at €17.80. The option has just €0.05 of extrinsic value left. You want to avoid buying the shares? Close or roll it. Want the stock? Then assignment is just execution.
  • Iron condor with breached put side: Your short put is in the money, long put still far out of the money. Close the short leg before expiration to avoid owning stock. You can still hold the long put if you expect a rebound—or close the entire side.

Final thoughts

Avoiding assignment is often just a matter of timing. Watch your short options for signs of declining time value. Monitor dividend schedules. And take a proactive approach to managing risk. Whether you want to avoid assignment—or accept it on your own terms—the more you understand the warning signs, the more control you’ll have.

It’s not about avoiding assignment at all costs. It’s about choosing when it works for you.

This material is marketing content and should not be regarded as investment advice. Trading financial instruments carries risks and historic performance is not a guarantee of future results.
The instrument(s) referenced in this content may be issued by a partner, from whom Saxo receives promotional fees, payment or retrocessions. While Saxo may receive compensation from these partnerships, all content is created with the aim of providing clients with valuable information and options..

Outrageous Predictions 2026

01 /

  • Executive Summary: Outrageous Predictions 2026

    Outrageous Predictions

    Executive Summary: Outrageous Predictions 2026

    Saxo Group

    Read Saxo's Outrageous Predictions for 2026, our latest batch of low probability, but high impact ev...
  • A Fortune 500 company names an AI model as CEO

    Outrageous Predictions

    A Fortune 500 company names an AI model as CEO

    Charu Chanana

    Chief Investment Strategist

    Can AI be trusted to take over in the boardroom? With the right algorithms and balanced human oversi...
  • Dollar dominance challenged by Beijing’s golden yuan

    Outrageous Predictions

    Dollar dominance challenged by Beijing’s golden yuan

    Charu Chanana

    Chief Investment Strategist

    Beijing does an end-run around the US dollar, setting up a framework for settling trade in a neutral...
  • Obesity drugs for everyone – even for pets

    Outrageous Predictions

    Obesity drugs for everyone – even for pets

    Jacob Falkencrone

    Global Head of Investment Strategy

    The availability of GLP-1 drugs in pill form makes them ubiquitous, shrinking waistlines, even for p...
  • Dumb AI triggers trillion-dollar clean-up

    Outrageous Predictions

    Dumb AI triggers trillion-dollar clean-up

    Jacob Falkencrone

    Global Head of Investment Strategy

    Agentic AI systems are deployed across all sectors, and after a solid start, mistakes trigger a tril...
  • Quantum leap Q-Day arrives early, crashing crypto and destabilizing world finance

    Outrageous Predictions

    Quantum leap Q-Day arrives early, crashing crypto and destabilizing world finance

    Neil Wilson

    Investor Content Strategist

    A quantum computer cracks today’s digital security, bringing enough chaos with it that Bitcoin crash...
  • Taylor Swift-Kelce wedding spikes global growth

    Outrageous Predictions

    Taylor Swift-Kelce wedding spikes global growth

    John J. Hardy

    Global Head of Macro Strategy

    Next year’s most anticipated wedding inspires Gen Z to drop the doomscrolling and dial up the real w...
  • SpaceX announces an IPO, supercharging extraterrestrial markets

    Outrageous Predictions

    SpaceX announces an IPO, supercharging extraterrestrial markets

    John J. Hardy

    Global Head of Macro Strategy

    Financial markets go into orbit, to the moon and beyond as SpaceX expands rocket launches by orders-...
  • Britain’s Great EU Backdoor Return

    Outrageous Predictions

    Britain’s Great EU Backdoor Return

    Neil Wilson

    Investor Content Strategist

    Faced with rolling fiscal, economic, trade and political crises the UK government sneaks back into t...
  • Despite concerns, U.S. 2026 mid-term elections proceed smoothly

    Outrageous Predictions

    Despite concerns, U.S. 2026 mid-term elections proceed smoothly

    John J. Hardy

    Global Head of Macro Strategy

    In spite of outstanding threats to the American democratic process, the US midterms come and go cord...

None of the information provided on this website constitutes an offer, solicitation, or endorsement to buy or sell any financial instrument, nor is it financial, investment, or trading advice. Saxo Capital Markets UK Ltd. (Saxo) and the Saxo Bank Group provides execution-only services, with all trades and investments based on self-directed decisions. Analysis, research, and educational content is for informational purposes only and should not be considered advice nor a recommendation. Access and use of this website is subject to: (i) the Terms of Use; (ii) the full Disclaimer; (iii) the Risk Warning; and (iv) any other notice or terms applying to Saxo’s news and research.

Saxo’s content may reflect the personal views of the author, which are subject to change without notice. Mentions of specific financial products are for illustrative purposes only and may serve to clarify financial literacy topics. Content classified as investment research is marketing material and does not meet legal requirements for independent research.

Before making any investment decisions, you should assess your own financial situation, needs, and objectives, and consider seeking independent professional advice. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

Please refer to our full disclaimer for more details. Past Performance is not indicative of future results.

Saxo
40 Bank Street, 26th floor
E14 5DA
London
United Kingdom

Contact Saxo

Select region

United Kingdom
United Kingdom

Trade Responsibly
All trading carries risk. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more
Additional Key Information Documents are available in our trading platform.

Saxo is a registered Trading Name of Saxo Capital Markets UK Ltd (‘Saxo’). Saxo is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871. Registered in England & Wales.

This website, including the information and materials contained in it, are not directed at, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in the United States, Belgium or any other jurisdiction where such distribution, publication, availability or use would be contrary to applicable law or regulation.

It is important that you understand that with investments, your capital is at risk. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. Saxo assumes no liability for any loss sustained from trading in accordance with a recommendation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Android is a trademark of Google Inc.

©   since 1992